Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Gastrointestinal Stromal Tumors (GIST) and a new revision number, while significant details about a clinical study comparing ripretinib and sunitinib have been removed.
    Difference
    21%
    Check dated 2025-04-16T14:22:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 5, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T08:55:46.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 5, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T23:12:11.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates from 2023 and 2024 while adding new dates in 2025. This indicates a shift in focus towards upcoming events or deadlines.
    Difference
    0.7%
    Check dated 2025-03-11T04:25:39.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T20:50:47.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:52:45.000Z thumbnail image

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.